Why isn’t MAPS sponsoring studies with ayahuasca, DMT, or salvia?
While we would like to sponsor studies into a variety of psychedelics, financial and human resources limit us. We have chosen to focus primarily on MDMA as a treatment for PTSD because it is realistic that we will be able to raise the necessary funds to conduct the studies to turn MDMA into a prescription medicine. If we were to acquire limitless resources we would fund a wider variety of research studies.
